...
ardx-img

Ardelyx Inc, Common Stock

ARDX

NMQ

$4.81

+$0.17

(3.66%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.08B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
4.40M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.91
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.32 L
$10.13 H
$4.81

About Ardelyx Inc, Common Stock

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameARDXSectorS&P500
1-Week Return2.56%2.44%2.58%
1-Month Return-10.09%-4.49%0.09%
3-Month Return-24.37%-8.82%4.76%
6-Month Return-21.28%-4.46%9.89%
1-Year Return-25.66%3.16%26.47%
3-Year Return345.37%-0.83%25.98%
5-Year Return-36.54%35.65%86.34%
10-Year Return-77.57%101.94%189.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue5.28M7.57M10.10M52.16M124.46M[{"date":"2019-12-31","value":4.24,"profit":true},{"date":"2020-12-31","value":6.08,"profit":true},{"date":"2021-12-31","value":8.11,"profit":true},{"date":"2022-12-31","value":41.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue600.00K145.00K1.00M4.12M17.80M[{"date":"2019-12-31","value":3.37,"profit":true},{"date":"2020-12-31","value":0.81,"profit":true},{"date":"2021-12-31","value":5.62,"profit":true},{"date":"2022-12-31","value":23.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit4.68M7.43M9.10M48.04M106.66M[{"date":"2019-12-31","value":4.39,"profit":true},{"date":"2020-12-31","value":6.96,"profit":true},{"date":"2021-12-31","value":8.53,"profit":true},{"date":"2022-12-31","value":45.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin88.64%98.08%90.10%92.11%85.70%[{"date":"2019-12-31","value":90.37,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.86,"profit":true},{"date":"2022-12-31","value":93.91,"profit":true},{"date":"2023-12-31","value":87.38,"profit":true}]
Operating Expenses95.94M98.21M163.44M111.80M169.94M[{"date":"2019-12-31","value":56.46,"profit":true},{"date":"2020-12-31","value":57.79,"profit":true},{"date":"2021-12-31","value":96.18,"profit":true},{"date":"2022-12-31","value":65.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(91.26M)(90.78M)(154.35M)(63.76M)(63.28M)[{"date":"2019-12-31","value":-9126300000,"profit":false},{"date":"2020-12-31","value":-9078000000,"profit":false},{"date":"2021-12-31","value":-15434600000,"profit":false},{"date":"2022-12-31","value":-6375900000,"profit":false},{"date":"2023-12-31","value":-6327600000,"profit":false}]
Total Non-Operating Income/Expense(9.10M)(8.63M)(8.32M)(8.51M)(11.12M)[{"date":"2019-12-31","value":-910000000,"profit":false},{"date":"2020-12-31","value":-863000000,"profit":false},{"date":"2021-12-31","value":-831700000,"profit":false},{"date":"2022-12-31","value":-851300000,"profit":false},{"date":"2023-12-31","value":-1111800000,"profit":false}]
Pre-Tax Income(94.64M)(94.31M)(158.16M)(67.20M)(65.52M)[{"date":"2019-12-31","value":-9463700000,"profit":false},{"date":"2020-12-31","value":-9431100000,"profit":false},{"date":"2021-12-31","value":-15816100000,"profit":false},{"date":"2022-12-31","value":-6719900000,"profit":false},{"date":"2023-12-31","value":-6552000000,"profit":false}]
Income Taxes303.00K2.00K4.00K8.00K547.00K[{"date":"2019-12-31","value":55.39,"profit":true},{"date":"2020-12-31","value":0.37,"profit":true},{"date":"2021-12-31","value":0.73,"profit":true},{"date":"2022-12-31","value":1.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(94.94M)(94.31M)(158.16M)(67.21M)(66.07M)[{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}]
Income From Continuous Operations(94.94M)(94.31M)(158.16M)(67.21M)(66.07M)[{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(94.94M)(94.31M)(158.16M)(67.21M)(66.07M)[{"date":"2019-12-31","value":-9494000000,"profit":false},{"date":"2020-12-31","value":-9431300000,"profit":false},{"date":"2021-12-31","value":-15816500000,"profit":false},{"date":"2022-12-31","value":-6720700000,"profit":false},{"date":"2023-12-31","value":-6606700000,"profit":false}]
EPS (Diluted)(1.47)(1.05)(1.52)(0.48)(0.30)[{"date":"2019-12-31","value":-147,"profit":false},{"date":"2020-12-31","value":-105,"profit":false},{"date":"2021-12-31","value":-152,"profit":false},{"date":"2022-12-31","value":-48,"profit":false},{"date":"2023-12-31","value":-30,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ARDX
Cash Ratio 2.70
Current Ratio 4.03
Quick Ratio 3.87

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ARDX
ROA (LTM) -12.18%
ROE (LTM) -41.54%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ARDX
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ARDX
Trailing PE NM
Forward PE NM
P/S (TTM) 4.31
P/B 6.85
Price/FCF 2980
EV/R 3.97
EV/Ebitda NM
PEG NM

FAQs

What is Ardelyx Inc share price today?

Ardelyx Inc (ARDX) share price today is $4.81

Can Indians buy Ardelyx Inc shares?

Yes, Indians can buy shares of Ardelyx Inc (ARDX) on Vested. To buy Ardelyx Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ARDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ardelyx Inc be purchased?

Yes, you can purchase fractional shares of Ardelyx Inc (ARDX) via the Vested app. You can start investing in Ardelyx Inc (ARDX) with a minimum investment of $1.

How to invest in Ardelyx Inc shares from India?

You can invest in shares of Ardelyx Inc (ARDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in ARDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ardelyx Inc shares
What is Ardelyx Inc 52-week high and low stock price?

The 52-week high price of Ardelyx Inc (ARDX) is $10.13. The 52-week low price of Ardelyx Inc (ARDX) is $4.32.

What is Ardelyx Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ardelyx Inc (ARDX) is

What is Ardelyx Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ardelyx Inc (ARDX) is 6.85

What is Ardelyx Inc dividend yield?

The dividend yield of Ardelyx Inc (ARDX) is 0.00%

What is the Market Cap of Ardelyx Inc?

The market capitalization of Ardelyx Inc (ARDX) is $1.08B

What is Ardelyx Inc’s stock symbol?

The stock symbol (or ticker) of Ardelyx Inc is ARDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top